Skip to content
CityAM
Main navigation
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • Canada BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Advertising at World Cup: Levi’s genius, hydration breaks and dodging rules

      Breaking news event with diverse crowd gathered outside urban office building on sunny day, capturing vibrant city life.

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
    • From our partners
      • The Morning Briefing: SBS x CityAM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Advertising at World Cup: Levi’s genius, hydration breaks and dodging rules

      Breaking news event with diverse crowd gathered outside urban office building on sunny day, capturing vibrant city life.

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      Procter & Gamble axes relationship with Kremlin propaganda channel

      007 PG news article image featuring a business meeting with executives discussing strategy at a modern conference table

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Latest Paper
What is City Talk? City Talk allows marketers to connect directly with our audience by publishing content on cityam.ca
Friday 09 April 2021 5:36 pm

Five big names who made CRISPR possible

By: Agathe Schwaar

Add as a preferred source on Google
NEW YORK, NY - JUNE 07: Technology Co-Inventor CRISPR-CAS9 Jennifer Doudna speaks onstage at WIRED Business Conference Presented By Visa At Spring Studios In New York City on June 7, 2017 in New York City. (Photo by Brian Ach/Getty Images for Wired)

Before becoming a reality, many of our craziest dreams had first been imagined in comics, movies and television shows. Being passionate about robotics and AI and also being a movie lover, I have devoured a large number of Sci-Fi movies, with Gattaca being one of my favourites.

In this movie, new generations of humans are created to be ‘perfect’ using careful genome selection at their birth. Children who do not go through ‘gene selection’ were stigmatized in a form of ‘genetic discrimination’ and were not considered to be a part of the new society.

Gene editing is yet another technology which has crossed over from science fiction into reality. For the past ten years we have had the right technology to edit genomes, called CRISPR technology. CRISPR (pronounced “crisper”) is shorthand for CRISPR-Cas9.  It is a DNA sequence within genomes of prokaryotic organisms such as bacteria and archaea.

By using the technology found within this sequence, researchers have been able to edit genomes and to explore new possibilities in modifying the function of specific genes, not only within crops and other organisms, but also with human genetics.

Some say that CRISPR represents a ‘singularity’ event that will change the world as we know it. Inevitably it is therefore attracting a lot of hype as well as interest from investors. Here is a list of the pioneers of CRISPR technology, and a short history of this innovative and disruptive discovery:

Jennifer Doudna & Emmanuelle Charpentier

Doudna and Charpentier are pioneers of CRISPR who have earned their place in history. Based on different continents (Jennifer Doudna in the United States and Emmanuelle Charpentier in Germany), together they discovered CRISPR-Cas9 ‘genetic scissors’. Their work was recognized in 2020 when they both received the Nobel Prize in Chemistry.

Jennifer Doudna & Emmanuelle Charpentier

Feng Zhang 

CRISPR research would not have reached the stage that it is now at without the brilliant work of Feng Zhang and his colleague Le Cong. Starting their work at the beginning of 2010, they started their research using genome editing tools for eukaryotic cells, leading them to publish a groundbreaking paper in 2013. Since then, Feng Zhang had received multiple awards for his CRISPR discoveries and is exploring the new possibilities to use this technology for brain disorders.

Feng Zhang 

Yoshizumi Ishino

Not that well known when it comes to the contemporary study in CRISPR, Yoshizumi Ishino was the first to discover CRISPR in 1987. The discovery was accidental; Yoshimizu and his team were sequencing a gene called iap from the gut microbe E.coli when they discovered a “genetic sandwich”: a series of unusual repetitive DNA sequences within repeated sequences. Yoshimizu Ishino had to wait a few years (and many researchers) before it was named “CRISPR.” He is still working on the sequence at the University of Kyushu in Japan.

Yoshizumi Ishino

Francisco Mojica

Without Francisco Mojica, there would not be any sequences called CRISPR. Following the discovery by Yoshizumi’s team in 1987, Francisco Mojica focused research onto those specific repeated sequences that were mixed within non-repeated sequences in archaeal species. He later coined the term “CRISPR” with Ruud Jenson, and in 2005, Francisco Mojica found the specific function of the CRISPR. He later tried to publish its discovery, but four different journals refused him.  Francisco Mojica is now considered one of the prominent pioneers in the discovery of CRISPR, and even though he did not receive the Nobel Prize, his work is regarded as one of the most important in the world of gene-editing tools.

Francisco Mojica
Read more

AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Related Topics

  • Rewired

Trending Articles

  • Who could be Andy Burnham’s Chancellor? 

  • As it happened: Stocks recover after markets rocked by tech-sell off; US claims ‘good foundations’ of Iran deal

  • As it happened: FTSE 100 finishes higher as US-Iran talks progress and Starmer resigns; Space X shares fall after bond sale

  • Coca-Cola brings in restructuring lineup over failed Costa sale

  • Starmer will resign, Trump says

More from CityAM

  • AviadoBio Expands vMiX™ Precision Gene Silencing Platform Exclusive License Agreement with King’s College London Beyond Neurological Diseases to All Human Therapeutic Areas

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • When AI’s taken all the work, what will we all do?

    Opinion
    Wall-E robot character in futuristic setting showcasing advanced robotics technology and innovation
  • Harbor Acquires CE Global Partners, Expanding HCM Advisory Practice with Specialist HR and Payroll Transformation Capabilities

    Business Wire
  • Controlling the sprawl of shadow AI

    Partner
    UK initiative to manage AI expansion, showcasing technology control measures in urban settings
  • Under the Shadow at Almeida: Psychological horror set against Tehran’s 1988 bombing

    Life&Style
    Mysterious urban landscape with tall buildings cast in shadow, highlighting architectural contrasts and atmospheric mood.
  • Smartstream Launches Smart Agents for Back-Office Operations, Proven Across Tier 1 Pilots

    Business Wire
  • Options Technology Offers Immediate Access to the Texas Stock Exchange (TXSE)

    Business Wire

CityAM Canada — business, markets and opinion for Canadian readers.

Sections

  • Business
  • Markets
  • Tech
  • AI
  • Economics
  • Opinion
  • Cities

Company

  • About
  • Contact

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 CityAM Canada. All rights reserved.
Terms · Privacy · Cookies